Active Refractory Rheumatoid Arthritis

Immunology·MeSH: Arthritis, Rheumatoid

Prevalence

800.0 / 100K

Incidence

41.0 / 100K/yr

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Active Refractory Rheumatoid Arthritis?

There are 1 clinical trial targeting Active Refractory Rheumatoid Arthritis tracked by BioSniper.

What is the prevalence of Active Refractory Rheumatoid Arthritis?

The estimated prevalence of Active Refractory Rheumatoid Arthritis is approximately 800.0 per 100,000 population.

Deep-dive into Active Refractory Rheumatoid Arthritis

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Active Refractory Rheumatoid Arthritis — Drugs in Development & Clinical Trials | BioSniper